These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 15358346

  • 1. Overexpression of human transforming growth factor-beta1 using a recombinant CHO cell expression system.
    Zou Z, Sun PD.
    Protein Expr Purif; 2004 Oct; 37(2):265-72. PubMed ID: 15358346
    [Abstract] [Full Text] [Related]

  • 2. Insulin-like growth factor-II/mannose 6 phosphate receptors facilitate the matrix effects of latent transforming growth factor-beta1 released from genetically modified keratinocytes in a fibroblast/keratinocyte co-culture system.
    Ghahary A, Tredget EE, Shen Q.
    J Cell Physiol; 1999 Jul; 180(1):61-70. PubMed ID: 10362018
    [Abstract] [Full Text] [Related]

  • 3. Expression and release of the latent transforming growth factor beta binding protein by hepatocytes from rat liver.
    Roth S, Schurek J, Gressner AM.
    Hepatology; 1997 Jun; 25(6):1398-405. PubMed ID: 9185759
    [Abstract] [Full Text] [Related]

  • 4. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3).
    Maeda S, Dean DD, Gomez R, Schwartz Z, Boyan BD.
    Calcif Tissue Int; 2002 Jan; 70(1):54-65. PubMed ID: 11907708
    [Abstract] [Full Text] [Related]

  • 5. Amino acid requirements for formation of the TGF-beta-latent TGF-beta binding protein complexes.
    Chen Y, Ali T, Todorovic V, O'leary JM, Kristina Downing A, Rifkin DB.
    J Mol Biol; 2005 Jan 07; 345(1):175-86. PubMed ID: 15567420
    [Abstract] [Full Text] [Related]

  • 6. An improved recombinant mammalian cell expression system for human transforming growth factor-beta2 and -beta3 preparations.
    Zou Z, Sun PD.
    Protein Expr Purif; 2006 Nov 07; 50(1):9-17. PubMed ID: 16901717
    [Abstract] [Full Text] [Related]

  • 7. Role of carbohydrate structures in the binding of beta1-latency-associated peptide to ligands.
    Yang Y, Dignam JD, Gentry LE.
    Biochemistry; 1997 Sep 30; 36(39):11923-32. PubMed ID: 9305986
    [Abstract] [Full Text] [Related]

  • 8. [Transfection of recombinant bone morphogenetic protein-7 expressing plasmid into cultured human renal tubular epithelial cells attenuates the extracellular matrix accumulation induced by transforming growth factor-beta].
    Li Y, Chen N, Yu HJ, Dong XP, Huang QH.
    Zhonghua Yi Xue Za Zhi; 2006 Feb 28; 86(8):544-8. PubMed ID: 16681885
    [Abstract] [Full Text] [Related]

  • 9. [Influence of recombinant transforming growth factor-beta3 on collagen synthesis and deposition: experiment with rat cell model of liver fibrosis].
    Li Q, Zhou X, Yu J, Qian W, Xu KS.
    Zhonghua Yi Xue Za Zhi; 2008 May 13; 88(18):1273-8. PubMed ID: 18844103
    [Abstract] [Full Text] [Related]

  • 10. Association of the small latent transforming growth factor-beta with an eight cysteine repeat of its binding protein LTBP-1.
    Saharinen J, Taipale J, Keski-Oja J.
    EMBO J; 1996 Jan 15; 15(2):245-53. PubMed ID: 8617200
    [Abstract] [Full Text] [Related]

  • 11. Characterization of TGF-beta-regulated interleukin-8 expression in human prostate cancer cells.
    Lu S, Dong Z.
    Prostate; 2006 Jun 15; 66(9):996-1004. PubMed ID: 16541418
    [Abstract] [Full Text] [Related]

  • 12. Parathyroid hormone stimulation and PKA signaling of latent transforming growth factor-beta binding protein-1 (LTBP-1) mRNA expression in osteoblastic cells.
    Kwok S, Qin L, Partridge NC, Selvamurugan N.
    J Cell Biochem; 2005 Aug 01; 95(5):1002-11. PubMed ID: 15880704
    [Abstract] [Full Text] [Related]

  • 13. Expression of recombinant human soluble type II transforming growth factor-beta receptor in Pichia pastoris and Escherichia coli: two powerful systems to express a potent inhibitor of transforming growth factor-beta.
    Glansbeek HL, van Beuningen HM, Vitters EL, van der Kraan PM, van den Berg WB.
    Protein Expr Purif; 1998 Mar 01; 12(2):201-7. PubMed ID: 9518461
    [Abstract] [Full Text] [Related]

  • 14. Horse cytokine/IgG fusion proteins--mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines.
    Wagner B, Robeson J, McCracken M, Wattrang E, Antczak DF.
    Vet Immunol Immunopathol; 2005 May 01; 105(1-2):1-14. PubMed ID: 15797470
    [Abstract] [Full Text] [Related]

  • 15. Transforming growth factor-beta1 upregulates myostatin expression in mouse C2C12 myoblasts.
    Budasz-Rwiderska M, Jank M, Motyl T.
    J Physiol Pharmacol; 2005 Jun 01; 56 Suppl 3():195-214. PubMed ID: 16077203
    [Abstract] [Full Text] [Related]

  • 16. The expression and antigenicity identification of recombinant rat TGF-beta1 in bacteria.
    Gao CF, Kong XT, Gressner AM, Weiskirchen R.
    Cell Res; 2001 Jun 01; 11(2):95-100. PubMed ID: 11453552
    [Abstract] [Full Text] [Related]

  • 17. Expression of recombinant extracellular domain of the type II transforming growth factor-beta receptor: utilization in a modified enzyme-linked immunoabsorbent assay to screen TGF-beta agonists and antagonists.
    Fahey MS, Dawbarn D, Allen SJ, Paterson IC, Prime SS.
    Anal Biochem; 2001 Mar 01; 290(2):272-6. PubMed ID: 11237329
    [Abstract] [Full Text] [Related]

  • 18. Expression of soluble recombinant TGF-beta type II receptor fused with the Fc portion of human IgG1 (sTbetaRII-Fc) in NS0 cells.
    Kwiatkowska EP, Kazimierczak U, Mackiewicz A, Kowalczyk DW.
    Acta Biochim Pol; 2006 Mar 01; 53(2):361-9. PubMed ID: 16733563
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of regucalcin suppresses cell response for tumor necrosis factor-alpha or transforming growth factor-beta1 in cloned normal rat kidney proximal tubular epithelial NRK52E cells.
    Nakagawa T, Yamaguchi M.
    J Cell Biochem; 2007 Apr 01; 100(5):1178-90. PubMed ID: 17063480
    [Abstract] [Full Text] [Related]

  • 20. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
    Samarakoon R, Higgins CE, Higgins SP, Kutz SM, Higgins PJ.
    J Cell Physiol; 2005 Jul 01; 204(1):236-46. PubMed ID: 15622520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.